Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Abbott Laboratories (ABT)

Abbott Laboratories (ABT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Quiver Markets Wrap: S&P 4 Day Losing Streak

Wall Street's main indexes faltered, marking their longest slump since January as investors grappled with a mix of rising bond yields and a tech sector sell-off, primarily led by significant losses in...

NVDA : 840.35 (-3.87%)
MS : 90.08 (+1.05%)
JPM : 180.08 (-0.40%)
WFC : 57.18 (+1.37%)
UAL : 48.74 (+17.45%)
UBS : 28.11 (+0.43%)
ABT : 105.90 (-3.03%)
Abbott Laboratories (ABT) Q1 2024 Earnings Call Transcript

ABT earnings call for the period ending March 31, 2024.

ABT : 105.90 (-3.03%)
Quiver Morning Wrap

Wall Street struggled to find footing on Wednesday, with the major indexes closing in the red as downbeat earnings and a downturn in chip stocks added to the market's woes. The Philadelphia Semiconductor...

NVDA : 840.35 (-3.87%)
JBHT : 168.13 (-8.12%)
USB : 39.52 (-3.61%)
ABT : 105.90 (-3.03%)
UAL : 48.74 (+17.45%)
AAL : 13.89 (+6.60%)
DAL : 47.88 (+2.86%)
LUV : 28.78 (+2.60%)
PLD : 106.49 (-7.19%)
TRV : 206.58 (-7.41%)
SPY : 500.55 (-0.59%)
QQQ : 425.84 (-1.22%)
Abbott Labs tops Q1 expectations, raises low end of 2024 guidance range

Abbott Laboratories on Wednesday reported first-quarter profit of $1.23 billion

ABT : 105.90 (-3.03%)
Abbott Labs Beats Earnings Estimates Due To Medical Device Sales

Abbott Laboratories (ABT) beat Wall Street estimates for its first quarter financial results due to ...

ABT : 105.90 (-3.03%)
Abbott: Q1 Earnings Snapshot

Abbott: Q1 Earnings Snapshot

ABT : 105.90 (-3.03%)
S&P Futures Climb as Investors Shift Focus to Earnings

June S&P 500 E-Mini futures (ESM24) are trending up +0.39% this morning as market participants moved past hawkish comments from Federal Reserve Chair Jerome Powell and looked ahead to the next round of...

ESM24 : 5,077.75 (+0.31%)
LYV : 91.82 (-0.42%)
BAC : 35.23 (+1.59%)
JNJ : 144.77 (+0.22%)
SMCI : 960.08 (-1.66%)
UNH : 478.99 (+2.15%)
ABT : 105.90 (-3.03%)
USB : 39.52 (-3.61%)
KMI : 17.76 (+0.40%)
LVS : 50.23 (-0.55%)
CSX : 34.16 (-1.95%)
ASML.NA : 850.400 (-0.23%)
Insiders, hedge funds, and politicians trading Abbott Laboratories stock (NYSE:ABT) in Q1 2024

$ABT earnings are coming up. Here is a look at recent trades of $ABT by people who might have an edge.CongressMembers of Congress have disclosed trades of $ABT stock 3 times in the last quarter. Of those...

ABT : 105.90 (-3.03%)
Stocks Set to Open Higher as Iran-Israel Tensions Ease, Earnings and Fed Speak in Focus

June S&P 500 E-Mini futures (ESM24) are up +0.44%, and June Nasdaq 100 E-Mini futures (NQM24) are up +0.52% this morning as market participants wagered that tensions in the Middle East won’t escalate...

ESM24 : 5,077.75 (+0.31%)
NQM24 : 17,736.25 (+0.44%)
ANET : 259.27 (-1.33%)
INTC : 35.68 (-1.60%)
AMD : 154.02 (-5.78%)
JPM : 180.08 (-0.40%)
GS : 403.91 (+1.78%)
BAC : 35.23 (+1.59%)
MS : 90.08 (+1.05%)
NFLX : 613.69 (-0.62%)
UNH : 478.99 (+2.15%)
JNJ : 144.77 (+0.22%)
Wholesale, Inflation Figures in Canada Due Next Week

Monday U.S. Economic Lookahead Retail Sales (March) Business inventories (Feb.) ...

GS.TO : 14.24 (-0.07%)
ABT : 105.90 (-3.03%)
PLD : 106.49 (-7.19%)
ELV : 508.97 (+0.39%)

Barchart Exclusives

This Outperforming Dividend Aristocrat Could Rally Another 22%, Says Analyst
With a track record of 30 years of dividend increases, this industrial stock is also delivering some outsized capital appreciation to shareholders lately. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar